Device Trial Radar · NCT07593625
Evaluating Glucose Control Using a Next-Generation AID Algorithm in Individuals With T1D
Last checked: Nov 20, 2026Latest source record: Sep 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
May 25, 2026
Primary completion
Dec 31, 2026
Study completion Feb 1, 2027
Sponsor
- Lead sponsor
- Insulet CorporationPublic (PODD)
- Sponsor type
- Industry
- First posted
- May 18, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 2 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Feasibility study to evaluate the safety and feasibility of Omnipod automated insulin delivery algorithms in individuals with type 1 diabetes. This study will enroll up to 80 participants to have a minimum of 48 participants to initiate the use of Omnipod. The study will include hotel and outpatient evaluation periods.
Conditions
- Type 1 Diabetes
- Type 1 Diabetes Mellitus
- Diabetes (DM)
Interventions
Omnipod M SystemDevice
Participants will use the Omnipod M System
Omnipod SDevice
Participants will use the Omnipod S System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of time <54 mg/dLTime frame: 72-hour Omnipod M Hotel Period
- Percentage of time <70 mg/dLTime frame: 72-hour Omnipod M Hotel Period
- Percentage of time >180 mg/dLTime frame: 72-hour Omnipod M Hotel Period
6 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Otago
Christchurch, New Zealand · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.